plumbagin has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudreau, LH; Gharib, E; Pichaud, N; Robichaud, GA; Veilleux, V | 1 |
| Chen, C; Chen, H; Tao, Z; Ying, X; Zhang, C; Zhang, H; Zheng, W | 1 |
2 other study(ies) available for plumbagin and Disease Exacerbation
| Article | Year |
|---|---|
Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming.
Topics: Antineoplastic Agents; Cell-Derived Microparticles; Cytarabine; Disease Progression; Humans; Leukemia, Lymphocytic, Chronic, B-Cell | 2023 |
Plumbagin Prevents IL-1β-Induced Inflammatory Response in Human Osteoarthritis Chondrocytes and Prevents the Progression of Osteoarthritis in Mice.
Topics: Adjuvants, Immunologic; Animals; Chondrocytes; Disease Progression; Humans; Inflammation; Interleukin-1beta; Mice; Naphthoquinones; NF-kappa B; Osteoarthritis; Signal Transduction | 2017 |